Dopamine suppresses pathological retinal oscillations and enhances the signal-to-noise ratio.

Dopamine activation of D1 receptors on A II amacrine cells suppresses retinal oscillations and improves signal clarity in a mouse model of infantile nystagmus.

• Why it matters: Infantile nystagmus causes severe visual impairment with no current cure, and understanding its retinal origins could lead to targeted treatments.
• What they did: Researchers used pharmacological activation of D1 dopaminergic receptors in Nyx nob mice, observing down-regulation of voltage-gated channels and elimination of pathological retinal oscillations through electrophysiology and simulations.
• The result: Suppressing these oscillations enhanced retinal signal fidelity, revealing a mechanistic pathway for dopaminergic regulation that could inform future therapies for nystagmus.